Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
The leukotriene E4 excretion following nasal aspirin challenges in patients with rhinitis and asthma assessed by two distinct methods Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007
Urinary leukotriene E4 during specific bronchial challenge testing in occupational asthma Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006
LATE-BREAKING ABSTRACT: The applicability of urinary leukotriene E4 (uLTE4) measurement as a non-invasive method for diagnosis of aspirin exacerbated respiratory disease (AERD). Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014
Measurement of leukotrienes urinary excretion in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005
Urinary leukotriene E4 after training exercise in children with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 478s Year: 2006
Current urinary leukotriene E4 and serum ECP but not current IL2R or total IgE are associated with persistent infant wheezing and/or regular medication use in a 6-year-old cohort previously recruited at first episode of wheeze Source: Eur Respir J 2001; 18: Suppl. 33, 128s Year: 2001
Changes in urinary LTE4 and acustic rhinomanometry following nasal challenge with ASA in ASA-tolerant and ASA-intolerant asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002
Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Nasal polyps support a higher LTE4 urinary excretion in aspirin-induced asthma (AIA) Source: Eur Respir J 2004; 24: Suppl. 48, 509s Year: 2004
Urinary leukotriene E4 in preschool children with acute clinical viral wheeze Source: Eur Respir J 2003; 21: 149-154 Year: 2003
Late-breaking abstract: Urinary leukotriene E4 /exhaled nitric oxide ratio as a predictor of exercise-induced bronchoconstriction control by oral montelukast or inhaled corticosteroid Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011
Urinary cysteinyl leukotriene levels in acute asthma Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003
The incidence of nasal polyps and corresponding LTE4 levels in severe asthma Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008
Late Breaking Abstract - Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma Source: Eur Respir J 2004; 24: 226-230 Year: 2004
Endoscopic sinus surgery (ESS) attenuates aspirin-induced asthmatic reaction in patients with aspirin-intolerant asthma (AIA) Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Source: Eur Respir J 2008; 32: 437-442 Year: 2008
Late Breaking Abstract - Influence of omalizumab therapy on airway remodelling assessed with high-resolution computed tomography (HRCT) in severe allergic asthma patients Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018